Merus Labs International (Merus Labs International) Interest Expense : $-4.89 Mil (TTM As of Mar. 2017)

View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Merus Labs International's interest expense for the three months ended in Mar. 2017 was $ -1.44 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2017 was $-4.89 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Merus Labs International's Operating Income for the three months ended in Mar. 2017 was $ 1.06 Mil. Merus Labs International's Interest Expense for the three months ended in Mar. 2017 was $ -1.44 Mil. Merus Labs International's Interest Coverage for the quarter that ended in Mar. 2017 was 0.73. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Merus Labs International Interest Expense Historical Data

The historical data trend for Merus Labs International's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International Interest Expense Chart

Merus Labs International Annual Data

Trend

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Interest Expense

Get a 7-Day Free Trial

-1.50

-5.28

-3.15

-4.01

-5.15

Merus Labs International Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Interest Expense	Get a 7-Day Free Trial															-1.25	-1.81	-0.34	-1.29	-1.44

Merus Labs International Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.89 Mil.

Merus Labs International (NAS:MSLI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Merus Labs International's Interest Expense for the three months ended in Mar. 2017 was $-1.44 Mil. Its Operating Income for the three months ended in Mar. 2017 was $1.06 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2017 was $70.01 Mil.

Merus Labs International's Interest Coverage for the quarter that ended in Mar. 2017 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2017 )	/	Interest Expense (Q: Mar. 2017 )
	=	-1	*	1.055	/	-1.44
	=	0.73

The higher the ratio, the stronger the company's financial strength is.

Merus Labs International (Merus Labs International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.meruslabs.com

Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines

From GuruFocus

Merus Labs International: A Pharma Stock With Growth Potential

By Gordon Pape Gordon Pape • 03-30-2015

Slow Growth Ahead; Updates on Merus Labs International, Enghouse Systems, Athabasca Minerals

By Gordon Pape Gordon Pape • 10-05-2015

Update on Merus Labs International, Athabasca Minerals Inc, Enghouse Systems Limited, WiLAN Inc.

By Gordon Pape Gordon Pape • 06-22-2015